Petros Pharmaceuticals, Inc. financial data

Symbol
PTPI on Nasdaq
Industry
Pharmaceutical Preparations
Location
1185 Avenue Of The Americas, 3 Rd Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 141 % -35.8%
Quick Ratio 13.5 % -52.6%
Debt-to-equity 225 % +49.4%
Return On Equity -57.2 % +41.4%
Return On Assets -17.2 % +55.8%
Operating Margin -338 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10M shares +355%
Common Stock, Shares, Outstanding 10M shares +372%
Entity Public Float 3.15M USD -75%
Common Stock, Value, Issued 1K USD +375%
Weighted Average Number of Shares Outstanding, Basic 9.83M shares +364%
Weighted Average Number of Shares Outstanding, Diluted 9.83M shares +364%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 4.02M USD -5.87%
Research and Development Expense 3.35M USD +91%
Operating Income (Loss) -13.6M USD -7.16%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.73M USD +51.2%
Income Tax Expense (Benefit) 10.5K USD +348%
Net Income (Loss) Attributable to Parent -4.73M USD +62.8%
Earnings Per Share, Basic -4.23 USD/shares +37.2%
Earnings Per Share, Diluted -4.23 USD/shares +37.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.9M USD -78.3%
Accounts Receivable, after Allowance for Credit Loss, Current 1.95M USD -34.5%
Inventory, Net 1.41M USD -43.8%
Other Assets, Current 4.76K USD -91.7%
Assets, Current 10.7M USD -56.1%
Property, Plant and Equipment, Net 18.8K USD -40.3%
Operating Lease, Right-of-Use Asset 125K USD -52.1%
Intangible Assets, Net (Excluding Goodwill) 6.83M USD -30.1%
Other Assets, Noncurrent 294K USD
Assets 20.7M USD -46.8%
Accounts Payable, Current 1.6M USD +18.1%
Accrued Liabilities, Current 6.54M USD +69%
Liabilities, Current 12.6M USD +55.4%
Operating Lease, Liability, Noncurrent 138K USD -47.6%
Other Liabilities, Noncurrent 91.8K USD -39.3%
Liabilities 17.6M USD -44.8%
Retained Earnings (Accumulated Deficit) -104M USD -4.77%
Stockholders' Equity Attributable to Parent 3.12M USD -55.1%
Liabilities and Equity 20.7M USD -46.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.13M USD -51.6%
Net Cash Provided by (Used in) Financing Activities -1.12M USD -213%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 10M shares +372%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.26M USD -104%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.89M USD -78.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 142K USD
Deferred Tax Assets, Valuation Allowance 18.1M USD +5.86%
Operating Lease, Liability 263K USD -35.1%
Lessee, Operating Lease, Liability, to be Paid 319K USD -37.3%
Operating Lease, Liability, Current 125K USD -12.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 81.1K USD -47.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 155K USD -18%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 56K USD -45.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 82.3K USD +1.5%
Deferred Tax Assets, Operating Loss Carryforwards 9.48M USD +57.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 82.3K USD +1.5%
Operating Lease, Payments 189K USD +0.87%
Additional Paid in Capital 107M USD +0.86%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 2.96M USD -12.5%
Depreciation, Depletion and Amortization 2.98M USD -12.3%
Share-based Payment Arrangement, Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%